New Alzheimer’s Drug Heightens Debate Over FDA Accelerated Approval Process June 10, 2021 Auto Bot News 0 FDA’s approval of Biogen’s treatment for Alzheimer’s disease has raised questions about the agency’s accelerated approval process.